Helmuth Gehart

Helmuth Gehart

Auto-generated profile, based on publicly available information

Helmuth Gehart

ETH Zurich, Institute of Molecular Health Sciences, Zürich, Schweiz

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Cell
Verified
Journal Article
Open access
MHMeritxell Huch
Meritxell Huch
HGHelmuth Gehart
Helmuth Gehart
RBRuben van Boxtel
Ruben van Boxtel
KHKarien Hamer
Karien Hamer
FBFrancis Blokzijl
Francis Blokzijl
Hans CleversHans Clevers
Hans Clevers
Despite the enormous replication potential of the human liver, there are currently no culture systems available that sustain hepatocyte replication and/or function in vitro. We have shown previously that single mouse Lgr5+ liver stem cells can be expanded as epithelial organoids in vitro and can be differentiated into functional hepatocytes in vitro and in vivo. We now describe conditions allowing long-term expansion of adult bile duct-derived bipotent progenitor cells from human liver. The expanded cells are highly stable at the chromosome and structural level, while single base changes occur at very low rates. The cells can readily be converted into functional hepatocytes in vitro and upon transplantation in vivo. Organoids from α1-antitrypsin deficiency and Alagille syndrome patients mirror the in vivo pathology. Clonal long-term expansion of primary adult liver stem cells opens up experimental avenues for disease modeling, toxicology studies, regenerative medicine, and gene therapy.

14 November 2018 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
HGHelmuth Gehart
Helmuth Gehart
Hans CleversHans Clevers
Hans Clevers

1 November 2018 in Cell
Verified
Journal Article
Closed access
HHHuili Hu
Huili Hu
HGHelmuth Gehart
Helmuth Gehart
BABenedetta Artegiani
Benedetta Artegiani
CLCarmen Löpez-Iglesias
Carmen Löpez-Iglesias
FDFlorijn Dekkers
Florijn Dekkers
Hans CleversHans Clevers
Hans Clevers

1 February 2019 in Cell
Verified
Journal Article
Closed access
HGHelmuth Gehart
Helmuth Gehart
JEJohan H. van Es
Johan H. van Es
KHKarien Hamer
Karien Hamer
JBJoep Beumer
Joep Beumer
KKKai Kretzschmar
Kai Kretzschmar
Hans CleversHans Clevers
Hans Clevers

8 October 2010 in EMBO Reports
Verified
Journal Article
Open access
PDF file
HGHelmuth Gehart
Helmuth Gehart
SKSusann Kumpf
Susann Kumpf
AIArne Ittner
Arne Ittner
RRRomeo Ricci
Romeo Ricci
Mitogen‐activated protein kinase (MAPK) signalling occurs in response to almost any change in the extracellular or intracellular milieu that affects the metabolism of the cell, organ or the entire organism. MAPK‐dependent signal transduction is required for physiological metabolic adaptation, but inappropriate MAPK signalling contributes to the development of several interdependent pathological traits, collectively known as metabolic syndrome. Metabolic syndrome leads to life‐threatening clinical consequences, such as type 2 diabetes. This Review provides an overview of the MAPK‐signalling mechanisms that underly basic cellular metabolism, discussing their link to disease.

1 November 2008 in Blood
Verified
Journal Article
Closed access
PDF file
MKMarc A. Kerenyi
Marc A. Kerenyi
FGFlorian Grebien
Florian Grebien
HGHelmuth Gehart
Helmuth Gehart
MSManfred Schifrer
Manfred Schifrer
MAMatthias Artaker
Matthias Artaker
EMErnst W. Müllner
Ernst W. Müllner
Erythropoiesis strictly depends on signal transduction through the erythropoietin receptor (EpoR)–Janus kinase 2 (Jak2)–signal transducer and activator of transcription 5 (Stat5) axis, regulating proliferation, differentiation, and survival. The exact role of the transcription factor Stat5 in erythropoiesis remained puzzling, however, since the first Stat5-deficient mice carried a hypomorphic Stat5 allele, impeding full phenotypical analysis. Using mice completely lacking Stat5—displaying early lethality—we demonstrate that these animals suffer from microcytic anemia due to reduced expression of the antiapoptotic proteins Bcl-xL and Mcl-1 followed by enhanced apoptosis. Moreover, transferrin receptor-1 (TfR-1) cell surface levels on erythroid cells were decreased more than 2-fold on erythroid cells of Stat5−/− animals. This reduction could be attributed to reduced transcription of TfR-1 mRNA and iron regulatory protein 2 (IRP-2), the major translational regulator of TfR-1 mRNA stability in erythroid cells. Both genes were demonstrated to be direct transcriptional targets of Stat5. This establishes an unexpected mechanistic link between EpoR/Jak/Stat signaling and iron metabolism, processes absolutely essential for erythropoiesis and life.